封面
市場調查報告書
商品編碼
2051085

脈衝電場消融市場:按組件、模式、適應症、最終用戶和地區分類

Pulsed Field Ablation Market, By Component, By Modality By Indication, By End User, By Geography

出版日期: | 出版商: Coherent Market Insights | 英文 135 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

脈衝電場消融市場預計在 2026 年達到 22.2 億美元,預計到 2033 年將達到 160.6 億美元。預計從 2026 年到 2033 年,其複合年成長率將達到 32.7%。

報告範圍 報告詳情
基準年: 2025 2026年市場規模: 22.2億美元
歷史數據時期: 2020-2024 預測期: 2026-2033
2026年至2033年預測期間的複合年成長率: 32.70% 2033年市場規模預測: 160.6億美元

全球脈衝電場消融市場代表著心臟電生理學的突破性進步,它提供的非熱消融技術改變了心房顫動和其他心律不整的治療方式。

脈衝電場消融(PFA) 利用微秒級高壓電脈衝,在目標心肌組織中誘發不可逆的電穿孔,從而實現精準消融並保護周圍組織結構。這種創新方法克服了射頻消融術和冷凍消融等傳統熱消融方法的許多局限性,並顯著降低了對食道、膈神經和肺靜脈等鄰近器官造成附帶損傷的風險。

這項技術的組織選擇性使心臟科醫生能夠在實現有效消融的同時提高安全性,從而減少手術相關併發症並改善患者預後。隨著全球醫療系統優先考慮微創心臟介入治療和精準醫療方法,脈衝場消融(PFA)技術正受到電生理學家和心臟中心的廣泛關注。該市場涵蓋各種專為脈衝電場消融手術設計的導管系統、產生器和配件,持續的創新推動產品開發和臨床應用,並在已開發國家和新興國家的醫療市場中廣泛應用。

市場動態

全球脈衝電場消融市場的主要驅動力是全球範圍內心房顫動盛行率的不斷上升。心房顫動影響著數百萬患者,因此對更有效、更安全的消融技術的需求顯著成長。人口老化以及心血管疾病、高血壓和糖尿病發生率的上升,也顯著增加了需要心導管電氣燒灼術手術的患者族群。脈衝場消融(PFA)相較於傳統熱消融具有技術優勢,這是推動市場發展的主要因素,它能夠縮短手術時間、降低併發症率並改善臨床療效,從而促進電生理學家廣泛採用該技術。

有利的報銷政策以及包括FDA和CE認證在內的主要監管機構的核准,正在加速市場滲透,而醫療設備製造商不斷加大研發投入,持續推動創新和產品改進。然而,市場成長受到一些因素的限制,例如PFA系統所需的高額初始投資、熟練PFA手術的電生理醫師短缺,以及與成熟的熱消融技術相比,人們對其長期療效數據的擔憂。此外,新醫療設備核准的嚴格監管要求以及PFA手術潛在的技術複雜性,可能會阻礙某些地區的市場擴張。儘管如此,新興市場仍蘊藏著巨大的機遇,這些市場的特點是醫療基礎設施不斷完善、醫療旅遊業蓬勃發展以及人們對先進心臟治療的認知度不斷提高。

本次調查的主要特點

  • 本研究確定了各個細分市場的潛在商機,並說明了該市場具有吸引力的投資提案矩陣。
  • 此外,本研究還提供了有關市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域展望以及主要參與者採取的競爭策略的重要見解。
  • 本研究根據公司亮點、產品系列、主要特點、財務表現和策略等參數,對全球脈衝電場消融市場的主要參與者進行了分析。
  • 透過利用本報告中的見解,企業行銷負責人和經營團隊將能夠就未來的產品發布、型號升級、市場擴張和行銷策略做出明智的決策。
  • 這份全球脈衝電場消融市場報告的目標受群眾外包括產業內的各種相關人員,例如投資者、供應商、產品製造商、經銷商、新參與企業和金融分析師。
  • 透過分析全球脈衝電場消融市場中使用的各種策略矩陣,相關人員將能夠更輕鬆地做出決策。

目錄

第1章:研究目標與前提條件

  • 研究目標
  • 先決條件
  • 簡稱

第2章 市場展望

  • 報告說明
    • 市場定義和範圍
  • 執行摘要

第3章:市場動態、監管與趨勢分析

  • 市場動態
    • 促進因素
    • 抑制因子
    • 機會
  • 影響分析
  • 主要進展
  • 監管趨勢
  • 產品上市及核准
  • PEST分析
  • 波特的分析
  • 併購情景
  • 產業趨勢

第4章 全球脈衝電場消融市場:依組件分類,2021-2033年

  • 導管
  • 發電機
  • 電極
  • 其他配件

第5章 全球脈衝電場消融市場:依治療方式分類,2021-2033年

  • 獨立系統
  • 整合系統

第6章 全球脈衝電場消融市場:依適應症分類,2021-2033年

  • 心房顫動
  • 心臟以外的用途

第7章 全球脈衝電場消融市場:依最終使用者分類,2021-2033年

  • 醫院
  • 專科診所
  • 心臟導管檢查室
  • 門診手術中心
  • 研究和學術機構

第8章 全球脈衝電場消融市場:依地區分類,2021-2033年

  • 北美洲
    • 美國
    • 加拿大
  • 拉丁美洲
    • 巴西
    • 阿根廷
    • 墨西哥
    • 其他拉丁美洲國家
  • 歐洲
    • 德國
    • 英國
    • 西班牙
    • 法國
    • 義大利
    • 俄羅斯
    • 其他歐洲國家
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • 澳洲
    • 韓國
    • ASEAN
    • 其他亞太國家
  • 中東
    • 海灣合作理事會國家
    • 以色列
    • 其他中東國家
  • 非洲
    • 南非
    • 北非
    • 中非

第9章 競爭情勢

  • Medtronic
  • Boston Scientific
  • Abbott Laboratories
  • Johnson & Johnson
  • Philips Healthcare
  • AtriCure
  • CardioFocus
  • Biotronik
  • Stereotaxis
  • ConMed Corporation
  • Endosmart
  • MicroPort Scientific Corporation
  • Sorin Group(now part of LivaNova)
  • CryoLife
  • Hansen Medical

第10章 分析師建議

  • 機會分析
  • 分析師意見
  • Coherent Opportunity Map

第11章 參考文獻與調查方法

  • 參考
  • 調查方法
  • 關於本公司
簡介目錄
Product Code: CMI8477

Pulsed Field Ablation Market is estimated to be valued at USD 2.22 Bn in 2026 and is expected to reach USD 16.06 Bn by 2033, growing at a compound annual growth rate (CAGR) of 32.7% from 2026 to 2033.

Report Coverage Report Details
Base Year: 2025 Market Size in 2026: USD 2.22 Bn
Historical Data for: 2020 To 2024 Forecast Period: 2026 To 2033
Forecast Period 2026 to 2033 CAGR: 32.70% 2033 Value Projection: USD 16.06 Bn

The global pulsed field ablation market represents a revolutionary advancement in cardiac electrophysiology, offering a non-thermal ablation technology that has transformed the treatment landscape for atrial fibrillation and other cardiac arrhythmias.

Pulsed Field Ablation (PFA) utilizes high-voltage electrical pulses delivered in microsecond durations to create irreversible electroporation in targeted cardiac tissue, resulting in precise ablation while preserving surrounding structures. This innovative approach addresses critical limitations of traditional thermal ablation methods, including radiofrequency and cryoablation, by significantly reducing the risk of collateral damage to adjacent organs such as the esophagus, phrenic nerve, and pulmonary veins.

The technology's tissue-selective properties enable cardiologists to achieve effective ablation outcomes with enhanced safety profiles, leading to reduced procedural complications and improved patient outcomes. As healthcare systems worldwide prioritize minimally invasive cardiac interventions and precision medicine approaches, PFA technology has gained substantial traction among electrophysiologists and cardiac centers. The market encompasses various catheter systems, generators, and ancillary equipment designed specifically for pulsed field ablation procedures, with continuous technological innovations driving product development and clinical adoption across developed and emerging the healthcare markets globally.

Market Dynamics

The global pulsed field ablation market is primarily driven by the increasing prevalence of atrial fibrillation worldwide, affecting millions of patients and creating substantial demand for effective and safer ablation technologies. The growing aging population, coupled with rising incidence of cardiovascular diseases, hypertension, and diabetes, significantly contributes to the expanding patient pool requiring cardiac ablation procedures. Technological superiority of PFA over conventional thermal ablation methods serves as a major market driver, offering reduced procedure times, lower complication rates, and improved clinical outcomes, thereby encouraging widespread adoption among electrophysiologists.

Favorable reimbursement policies and regulatory approvals from key authorities including FDA and CE marking have accelerated market penetration, while increasing investments in research and development by medical device manufacturers continue to drive innovation and product enhancement. However, market growth faces certain restraints including high initial capital investments required for PFA systems, limited availability of trained electrophysiologists proficient in PFA procedures, and concerns regarding long-term efficacy data compared to established thermal ablation techniques. Additionally, stringent regulatory requirements for new device approvals and potential technical complexities associated with PFA procedures may impede market expansion in certain regions. Nevertheless, significant opportunities exist in emerging markets with improving healthcare infrastructure, growing medical tourism, and increasing awareness about advanced cardiac treatments.

Key Features of the Study

  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players.
  • It profiles key players in the global pulsed field ablation market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies.
  • Key companies covered as a part of this study include Medtronic, Boston Scientific, Abbott Laboratories, Johnson & Johnson, Philips Healthcare, AtriCure, CardioFocus, Biotronik, Stereotaxis, ConMed Corporation, Endosmart, MicroPort Scientific Corporation, Sorin Group (now part of LivaNova), CryoLife, and Hansen Medical.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
  • The global pulsed field ablation market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global pulsed field ablation market.

Market Segmentation

  • Component Insights (Revenue, USD Bn, 2021 - 2033)
  • Catheters
  • Generators
  • Electrodes
  • Other Accessories
  • Modality Insights (Revenue, USD Bn, 2021 - 2033)
  • Standalone Systems
  • Integrated Systems
  • Indication Insights (Revenue, USD Bn, 2021 - 2033)
  • Atrial Fibrillation
  • Non-Cardiac Applications
  • End User Insights (Revenue, USD Bn, 2021 - 2033)
  • Hospitals
  • Specialty Clinics
  • Cardiac Catheterization Labs
  • Ambulatory Surgical Centers
  • Research and Academic Institutes
  • Regional Insights (Revenue, USD Bn, 2021 - 2033)
  • North America
    • U.S.
    • Canada
  • Latin America
    • Brazil
    • Argentina
    • Mexico
    • Rest of Latin America
  • Europe
    • Germany
    • U.K.
    • Spain
    • France
    • Italy
    • Russia
    • Rest of Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
  • Middle East
    • GCC Countries
    • Israel
    • Rest of Middle East
  • Africa
    • South Africa
    • North Africa
    • Central Africa
  • Key Players Insights
  • Medtronic
  • Boston Scientific
  • Abbott Laboratories
  • Johnson & Johnson
  • Philips Healthcare
  • AtriCure
  • CardioFocus
  • Biotronik
  • Stereotaxis
  • ConMed Corporation
  • Endosmart
  • MicroPort Scientific Corporation
  • Sorin Group (now part of LivaNova)
  • CryoLife
  • Hansen Medical

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Global Pulsed Field Ablation Market, By Component
    • Global Pulsed Field Ablation Market, By Modality
    • Global Pulsed Field Ablation Market, By Indication
    • Global Pulsed Field Ablation Market, By End User
    • Global Pulsed Field Ablation Market, By Region

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Driver
    • Restraint
    • Opportunity
  • Impact Analysis
  • Key Developments
  • Regulatory Scenario
  • Product Launches/Approvals
  • PEST Analysis
  • PORTER's Analysis
  • Merger and Acquisition Scenario
  • Industry Trends

4. Global Pulsed Field Ablation Market, By Component, 2021 - 2033, (USD Bn)

  • Introduction
    • Market Share Analysis, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, 2022 - 2033
    • Segment Trends
  • Catheters
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
  • Generators
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
  • Electrodes
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
  • Other Accessories
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)

5. Global Pulsed Field Ablation Market, By Modality, 2021 - 2033, (USD Bn)

  • Introduction
    • Market Share Analysis, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, 2022 - 2033
    • Segment Trends
  • Standalone Systems
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
  • Integrated Systems
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)

6. Global Pulsed Field Ablation Market, By Indication, 2021 - 2033, (USD Bn)

  • Introduction
    • Market Share Analysis, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, 2022 - 2033
    • Segment Trends
  • Atrial Fibrillation
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
  • Non-Cardiac Applications
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)

7. Global Pulsed Field Ablation Market, By End User, 2021 - 2033, (USD Bn)

  • Introduction
    • Market Share Analysis, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, 2022 - 2033
    • Segment Trends
  • Hospitals
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
  • Specialty Clinics
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
  • Cardiac Catheterization Labs
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
  • Ambulatory Surgical Centers
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
  • Research and Academic Institutes
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)

8. Global Pulsed Field Ablation Market, By Region, 2021 - 2033, Value (USD Bn)

  • Introduction
    • Market Share (%) Analysis, 2026, 2028 & 2033, Value (USD Bn)
    • Market Y-o-Y Growth Analysis (%), 2022 - 2033, Value (USD Bn)
    • Regional Trends
  • North America
    • Introduction
    • Market Size and Forecast, By Component, 2021 - 2033, Value (USD Bn)
    • Market Size and Forecast, By Modality, 2021 - 2033, Value (USD Bn)
    • Market Size and Forecast, By Indication, 2021 - 2033, Value (USD Bn)
    • Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
    • Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
      • U.S.
      • Canada
  • Latin America
    • Introduction
    • Market Size and Forecast, By Component, 2021 - 2033, Value (USD Bn)
    • Market Size and Forecast, By Modality, 2021 - 2033, Value (USD Bn)
    • Market Size and Forecast, By Indication, 2021 - 2033, Value (USD Bn)
    • Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
    • Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
      • Brazil
      • Argentina
      • Mexico
      • Rest of Latin America
  • Europe
    • Introduction
    • Market Size and Forecast, By Component, 2021 - 2033, Value (USD Bn)
    • Market Size and Forecast, By Modality, 2021 - 2033, Value (USD Bn)
    • Market Size and Forecast, By Indication, 2021 - 2033, Value (USD Bn)
    • Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
    • Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
      • Germany
      • U.K.
      • Spain
      • France
      • Italy
      • Russia
      • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, By Component, 2021 - 2033, Value (USD Bn)
    • Market Size and Forecast, By Modality, 2021 - 2033, Value (USD Bn)
    • Market Size and Forecast, By Indication, 2021 - 2033, Value (USD Bn)
    • Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
    • Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
      • China
      • India
      • Japan
      • Australia
      • South Korea
      • ASEAN
      • Rest of Asia Pacific
  • Middle East
    • Introduction
    • Market Size and Forecast, By Component, 2021 - 2033, Value (USD Bn)
    • Market Size and Forecast, By Modality, 2021 - 2033, Value (USD Bn)
    • Market Size and Forecast, By Indication, 2021 - 2033, Value (USD Bn)
    • Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
    • Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
      • GCC Countries
      • Israel
      • Rest of Middle East
  • Africa
    • Introduction
    • Market Size and Forecast, By Component, 2021 - 2033, Value (USD Bn)
    • Market Size and Forecast, By Modality, 2021 - 2033, Value (USD Bn)
    • Market Size and Forecast, By Indication, 2021 - 2033, Value (USD Bn)
    • Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
    • Market Size and Forecast, By Country/Region, 2021 - 2033, Value (USD Bn)
      • South Africa
      • North Africa
      • Central Africa

9. Competitive Landscape

  • Medtronic
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Boston Scientific
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Abbott Laboratories
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Johnson & Johnson
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Philips Healthcare
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • AtriCure
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • CardioFocus
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Biotronik
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Stereotaxis
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • ConMed Corporation
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Endosmart
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • MicroPort Scientific Corporation
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Sorin Group (now part of LivaNova)
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • CryoLife
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Hansen Medical
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies

10. Analyst Recommendations

  • Wheel of Fortune
  • Analyst View
  • Coherent Opportunity Map

11. References and Research Methodology

  • References
  • Research Methodology
  • About Us